{
  "data": {
    "id": "org_european-medicines-agency",
    "slug": "european-medicines-agency",
    "name": "European Medicines Agency",
    "short_name": "EMA",
    "type": "government",
    "tier": 1,
    "homepage": "https://www.ema.europa.eu",
    "country_code": "NL",
    "reliability_note": null,
    "url": "https://statorigin.org/sources/european-medicines-agency",
    "documents": [
      {
        "title": "Human medicines: highlights of 2022",
        "url": "https://www.ema.europa.eu/en/news/human-medicines-highlights-2022",
        "doc_type": "press_release",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 2
      },
      {
        "title": "EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines",
        "url": "https://www.ema.europa.eu/en/news/emas-2025-annual-report-shows-strong-approval-numbers-human-veterinary-medicines",
        "doc_type": "press_release",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 3
      },
      {
        "title": "Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026",
        "url": "https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-july-2026",
        "doc_type": "press_release",
        "published_date": null,
        "accessed_at": "2026-09-15",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 2
      }
    ],
    "statistics": [
      {
        "id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGF6",
        "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF6",
        "indicator": {
          "slug": "generic-medicines-receiving-positive-opinion-monthly",
          "name": "Generic medicines receiving positive opinion (monthly)",
          "definition": "Number of generic medicines receiving a positive opinion from the medicines regulatory committee at its monthly meeting."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "EU",
          "name": "European Union",
          "type": "bloc"
        },
        "period": {
          "start": "2026-07-01",
          "end": "2026-07-31",
          "type": "month"
        },
        "value": 3,
        "value_text": "Three",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "European Medicines Agency",
          "org_short_name": "EMA",
          "org_url": "https://www.ema.europa.eu",
          "org_tier": 1,
          "document_title": "Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026",
          "document_url": "https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-july-2026",
          "document_type": "press_release",
          "locator": "Twelve new medicines recommended for approval",
          "quote": "Three generic medicines received a positive opinion:",
          "published_date": null,
          "accessed_at": "2026-09-15",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-15T22:15:46.809Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "European Medicines Agency. (2026). Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026. Retrieved September 15, 2026, from https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-july-2026. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF6",
          "bibtex": "@misc{ema2026genericbjmgf6,\n  author       = {{European Medicines Agency}},\n  title        = {Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF6},\n  note         = {Original source: https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-july-2026. Accessed September 15, 2026.}\n}"
        },
        "updated_at": "2026-09-15T22:15:46.809Z"
      },
      {
        "id": "stat_2WF04Y2R5Z04SP8DHEFFMFTJYX",
        "url": "https://statorigin.org/stat/stat_2WF04Y2R5Z04SP8DHEFFMFTJYX",
        "indicator": {
          "slug": "human-medicines-recommended-for-marketing-authorization",
          "name": "Human medicines recommended for marketing authorization",
          "definition": "Total number of medicines for human use recommended for marketing authorization by the regulatory authority."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "EU",
          "name": "European Union",
          "type": "bloc"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 104,
        "value_text": "104",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "European Medicines Agency",
          "org_short_name": "EMA",
          "org_url": "https://www.ema.europa.eu",
          "org_tier": 1,
          "document_title": "EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines",
          "document_url": "https://www.ema.europa.eu/en/news/emas-2025-annual-report-shows-strong-approval-numbers-human-veterinary-medicines",
          "document_type": "press_release",
          "locator": "EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines",
          "quote": "In 2025, EMA recommended 104 human medicines for marketing authorisation.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "European Medicines Agency. (2025). EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines. Retrieved September 17, 2026, from https://www.ema.europa.eu/en/news/emas-2025-annual-report-shows-strong-approval-numbers-human-veterinary-medicines. Via StatOrigin, https://statorigin.org/stat/stat_2WF04Y2R5Z04SP8DHEFFMFTJYX",
          "bibtex": "@misc{ema2025humanmftjyx,\n  author       = {{European Medicines Agency}},\n  title        = {EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_2WF04Y2R5Z04SP8DHEFFMFTJYX},\n  note         = {Original source: https://www.ema.europa.eu/en/news/emas-2025-annual-report-shows-strong-approval-numbers-human-veterinary-medicines. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_N6X2GMB3Q4Y7Q9FAVAD19T8Z83",
        "url": "https://statorigin.org/stat/stat_N6X2GMB3Q4Y7Q9FAVAD19T8Z83",
        "indicator": {
          "slug": "human-medicines-recommended-for-marketing-authorization-with-new-active-substanc",
          "name": "Human medicines recommended for marketing authorization with new active substance",
          "definition": "Number of medicines for human use recommended for marketing authorization containing a new active substance."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "EU",
          "name": "European Union",
          "type": "bloc"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 38,
        "value_text": "38",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "European Medicines Agency",
          "org_short_name": "EMA",
          "org_url": "https://www.ema.europa.eu",
          "org_tier": 1,
          "document_title": "EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines",
          "document_url": "https://www.ema.europa.eu/en/news/emas-2025-annual-report-shows-strong-approval-numbers-human-veterinary-medicines",
          "document_type": "press_release",
          "locator": "EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines",
          "quote": "Of these, 38 had a new active substance which had never been authorised in the European Union (EU) before.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "European Medicines Agency. (2025). EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines. Retrieved September 17, 2026, from https://www.ema.europa.eu/en/news/emas-2025-annual-report-shows-strong-approval-numbers-human-veterinary-medicines. Via StatOrigin, https://statorigin.org/stat/stat_N6X2GMB3Q4Y7Q9FAVAD19T8Z83",
          "bibtex": "@misc{ema2025human9t8z83,\n  author       = {{European Medicines Agency}},\n  title        = {EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_N6X2GMB3Q4Y7Q9FAVAD19T8Z83},\n  note         = {Original source: https://www.ema.europa.eu/en/news/emas-2025-annual-report-shows-strong-approval-numbers-human-veterinary-medicines. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_JYQQX5HH7JXNA7QVFF4ESPABTP",
        "url": "https://statorigin.org/stat/stat_JYQQX5HH7JXNA7QVFF4ESPABTP",
        "indicator": {
          "slug": "human-rare-disease-medicines-recommended-for-marketing-authorisation",
          "name": "Human rare disease medicines recommended for marketing authorisation",
          "definition": "Number of medicines for human use indicated for the treatment of rare diseases recommended for marketing authorisation."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "EU",
          "name": "European Union",
          "type": "bloc"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 16,
        "value_text": "Sixteen",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "European Medicines Agency",
          "org_short_name": "EMA",
          "org_url": "https://www.ema.europa.eu",
          "org_tier": 1,
          "document_title": "EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines",
          "document_url": "https://www.ema.europa.eu/en/news/emas-2025-annual-report-shows-strong-approval-numbers-human-veterinary-medicines",
          "document_type": "press_release",
          "locator": "EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines",
          "quote": "Sixteen of the recommended human medicines were for the treatment of rare diseases.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "European Medicines Agency. (2025). EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines. Retrieved September 17, 2026, from https://www.ema.europa.eu/en/news/emas-2025-annual-report-shows-strong-approval-numbers-human-veterinary-medicines. Via StatOrigin, https://statorigin.org/stat/stat_JYQQX5HH7JXNA7QVFF4ESPABTP",
          "bibtex": "@misc{ema2025humanspabtp,\n  author       = {{European Medicines Agency}},\n  title        = {EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_JYQQX5HH7JXNA7QVFF4ESPABTP},\n  note         = {Original source: https://www.ema.europa.eu/en/news/emas-2025-annual-report-shows-strong-approval-numbers-human-veterinary-medicines. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_N4C8RCYJBPFCCBAS92PS6N9CGN",
        "url": "https://statorigin.org/stat/stat_N4C8RCYJBPFCCBAS92PS6N9CGN",
        "indicator": {
          "slug": "medicines-recommended-for-marketing-authorisation",
          "name": "Medicines recommended for marketing authorisation",
          "definition": "Total number of medicines recommended for marketing authorisation by the regulatory authority."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "EU",
          "name": "European Union",
          "type": "bloc"
        },
        "period": {
          "start": "2022-01-01",
          "end": "2022-12-31",
          "type": "year"
        },
        "value": 89,
        "value_text": "89",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "European Medicines Agency",
          "org_short_name": "EMA",
          "org_url": "https://www.ema.europa.eu",
          "org_tier": 1,
          "document_title": "Human medicines: highlights of 2022",
          "document_url": "https://www.ema.europa.eu/en/news/human-medicines-highlights-2022",
          "document_type": "press_release",
          "locator": "Update as of 3 March 2026",
          "quote": "In 2022, EMA recommended 89 medicines for marketing authorisation.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "European Medicines Agency. (2022). Human medicines: highlights of 2022. Retrieved September 17, 2026, from https://www.ema.europa.eu/en/news/human-medicines-highlights-2022. Via StatOrigin, https://statorigin.org/stat/stat_N4C8RCYJBPFCCBAS92PS6N9CGN",
          "bibtex": "@misc{ema2022medicines6n9cgn,\n  author       = {{European Medicines Agency}},\n  title        = {Human medicines: highlights of 2022},\n  year         = {2022},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_N4C8RCYJBPFCCBAS92PS6N9CGN},\n  note         = {Original source: https://www.ema.europa.eu/en/news/human-medicines-highlights-2022. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_M6S01C976QWYFKEGN8SMWPT6AJ",
        "url": "https://statorigin.org/stat/stat_M6S01C976QWYFKEGN8SMWPT6AJ",
        "indicator": {
          "slug": "medicines-with-new-active-substances-recommended-for-marketing-authorisation",
          "name": "Medicines with new active substances recommended for marketing authorisation",
          "definition": "Number of medicines containing a new active substance not previously authorised recommended for marketing authorisation."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "EU",
          "name": "European Union",
          "type": "bloc"
        },
        "period": {
          "start": "2022-01-01",
          "end": "2022-12-31",
          "type": "year"
        },
        "value": 42,
        "value_text": "42",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "European Medicines Agency",
          "org_short_name": "EMA",
          "org_url": "https://www.ema.europa.eu",
          "org_tier": 1,
          "document_title": "Human medicines: highlights of 2022",
          "document_url": "https://www.ema.europa.eu/en/news/human-medicines-highlights-2022",
          "document_type": "press_release",
          "locator": "Update as of 3 March 2026",
          "quote": "Of these, 42 had a new active substance which had never been authorised in the European Union (EU) before.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "European Medicines Agency. (2022). Human medicines: highlights of 2022. Retrieved September 17, 2026, from https://www.ema.europa.eu/en/news/human-medicines-highlights-2022. Via StatOrigin, https://statorigin.org/stat/stat_M6S01C976QWYFKEGN8SMWPT6AJ",
          "bibtex": "@misc{ema2022medicineswpt6aj,\n  author       = {{European Medicines Agency}},\n  title        = {Human medicines: highlights of 2022},\n  year         = {2022},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_M6S01C976QWYFKEGN8SMWPT6AJ},\n  note         = {Original source: https://www.ema.europa.eu/en/news/human-medicines-highlights-2022. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGF5",
        "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF5",
        "indicator": {
          "slug": "new-medicines-recommended-for-approval-monthly",
          "name": "New medicines recommended for approval (monthly)",
          "definition": "Number of new medicines recommended for marketing authorisation by the medicines regulatory committee at its monthly meeting."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "EU",
          "name": "European Union",
          "type": "bloc"
        },
        "period": {
          "start": "2026-07-01",
          "end": "2026-07-31",
          "type": "month"
        },
        "value": 12,
        "value_text": "twelve",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "European Medicines Agency",
          "org_short_name": "EMA",
          "org_url": "https://www.ema.europa.eu",
          "org_tier": 1,
          "document_title": "Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026",
          "document_url": "https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-july-2026",
          "document_type": "press_release",
          "locator": "Twelve new medicines recommended for approval",
          "quote": "EMA’s human medicines committee (CHMP) recommended twelve medicines for approval at its July 2026 meeting.",
          "published_date": null,
          "accessed_at": "2026-09-15",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-15T22:15:46.809Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "European Medicines Agency. (2026). Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026. Retrieved September 15, 2026, from https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-july-2026. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF5",
          "bibtex": "@misc{ema2026medicinesbjmgf5,\n  author       = {{European Medicines Agency}},\n  title        = {Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF5},\n  note         = {Original source: https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-july-2026. Accessed September 15, 2026.}\n}"
        },
        "updated_at": "2026-09-15T22:15:46.809Z"
      }
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 7,
    "note": "Statistics are capped at 100 per request. Use /statistics?source_org=european-medicines-agency with a cursor to page through everything."
  }
}